PEN logo

Penumbra (PEN) EBITDA

Annual EBITDA

$45.99 M
-$62.66 M-57.67%

December 31, 2024

Summary

Performance

1-Year Change

-57.67%

3-Year Change

+486.67%

5-Year Change

-17.3%

15-Year Change

+829.82%

PEN EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

85.13%
PEN annual EBITDA is higher than 85.13% of companies in Healthcare sector

High & Low

All-time High

$108.65 M
PEN annual EBITDA is currently -57.67% below its historical high of $108.65 million

3-Year Low

$7.84 M
PEN annual EBITDA is currently +486.67% above its 3-year low

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2024
PEN previous annual earnings announcement was published on Dec 31, 2024

Next Annual Earnings Report Date

N/A
PEN next annual earnings announcement has not yet been scheduled

OtherPENprofitabilitymetrics:

Annual Revenue

$1.19 B
PEN annual revenue is $1.19 billion

Annual Net Income

$14.01 M
PEN annual net profit is $14.01 million

Annual EBIT

$22.29 M
PEN annual earnings before interest & taxes is $22.29 million

Annual EPS

$0.36
PEN annual earnings per share is $0.36

Quarterly EBITDA

$49.06 M
+$4.80 M+10.85%

December 31, 2024

Summary

Performance

3-Month Change

0%

1-Year Change

0%

3-Year Change

0%

5-Year Change

0%

PEN Quarterly EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

87.77%
PEN quarterly EBITDA is higher than 87.77% of companies in Healthcare sector

High & Low

All-time High

$49.06 M
PEN quarterly EBITDA is currently at an all-time high

3-Year Low

-$69.88 M

Earnings dates

Last Quarterly Earnings Report Date

Dec 31, 2024
PEN previous earnings announcement was published on Dec 31, 2024

Next Quarterly Earnings Report Date

May 7, 2025
PEN next earnings announcement is scheduled for May 7, 2025

OtherPENprofitabilitymetrics:

Quarterly Revenue

$315.52 M
PEN quarterly revenue is $315.52 million

Quarterly Net Income

$33.68 M
PEN quarterly net profit is $33.68 million

Quarterly EBIT

$44.68 M
PEN quarterly earnings before interest & taxes is $44.68 million

Quarterly EPS

$0.86
PEN quarterly earnings per share is $0.86

TTM EBITDA

$43.06 M
+$3.43 M+8.66%

December 31, 2024

Summary

Performance

3-Month Change

0%

1-Year Change

0%

3-Year Change

0%

5-Year Change

0%

PEN TTM EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

83.73%
PEN TTM EBITDA is higher than 83.73% of companies in Healthcare sector

High & Low

All-time High

$112.62 M
PEN TTM EBITDA is currently -61.76% below its historical high of $112.62 million

3-Year Low

-$16.24 M

Earnings dates

Last Quarterly Earnings Report Date

Dec 31, 2024
PEN previous earnings announcement was published on Dec 31, 2024

Next Quarterly Earnings Report Date

May 7, 2025
PEN next earnings announcement is scheduled for May 7, 2025

OtherPENprofitabilitymetrics:

TTM Revenue

$1.19 B
PEN TTM revenue is $1.19 billion

TTM Net Income

$14.01 M
PEN TTM net profit is $14.01 million

TTM EBIT

$19.36 M
PEN TTM earnings before interest & taxes is $19.36 million

TTM EPS

$0.34
PEN TTM earnings per share is $0.34

EBITDA Formula

EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization

Annual EBITDA

$45.99 M
PEN annual EBITDA is $45.99 million

Annual Net Income

$14.01 M
PEN annual net profit is $14.01 million

Annual Interest Expense

$1.42 M
PEN annual interest expense is $1.42 million

Annual Income Tax

$6.86 M
PEN annual income tax is $6.86 million

Annual D&A

$23.70 M
PEN annual depreciation & amortization is $23.70 million

PEN EBITDA Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-57.7%0.0%0.0%
3 y3 years+486.7%0.0%0.0%
5 y5 years-17.3%0.0%0.0%

PEN EBITDA Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-57.7%+486.7%at high+170.2%-61.8%+365.1%
5 y5-year-57.7%+276.5%at high+170.2%-61.8%+265.3%
alltimeall time-57.7%+276.5%at high+170.2%-61.8%+265.3%

Penumbra EBITDA History

DateAnnualQuarterlyTTM
Dec 2024
$45.99 M(-57.7%)
$49.06 M(+10.8%)
$43.06 M(+8.7%)
Sep 2024
-
$44.26 M(-163.3%)
$39.63 M(+146.9%)
Jun 2024
-
-$69.88 M(-456.2%)
$16.05 M(-85.7%)
Mar 2024
-
$19.62 M(-57.0%)
$112.62 M(+4.7%)
Dec 2023
$108.65 M(+262.6%)
$45.63 M(+120.7%)
$107.58 M(+47.8%)
Sep 2023
-
$20.68 M(-22.5%)
$72.78 M(+14.1%)
Jun 2023
-
$26.69 M(+83.0%)
$63.77 M(+48.8%)
Mar 2023
-
$14.58 M(+34.6%)
$42.87 M(+43.1%)
Dec 2022
$29.96 M(+282.2%)
$10.83 M(-7.1%)
$29.96 M(-284.5%)
Sep 2022
-
$11.66 M(+101.4%)
-$16.24 M(+4.9%)
Jun 2022
-
$5.79 M(+244.6%)
-$15.49 M(+108.9%)
Mar 2022
-
$1.68 M(-104.7%)
-$7.42 M(-194.6%)
Dec 2021
$7.84 M(-130.1%)
-$35.37 M(-384.9%)
$7.84 M(-82.6%)
Sep 2021
-
$12.41 M(-10.5%)
$44.92 M(+186.2%)
Jun 2021
-
$13.86 M(-18.1%)
$15.70 M(-223.7%)
Mar 2021
-
$16.93 M(+888.6%)
-$12.69 M(-51.3%)
Dec 2020
-$26.05 M(-146.8%)
$1.71 M(-110.2%)
-$26.05 M(+75.2%)
Sep 2020
-
-$16.82 M(+15.8%)
-$14.87 M(-187.6%)
Jun 2020
-
-$14.52 M(-506.8%)
$16.97 M(-63.3%)
Mar 2020
-
$3.57 M(-72.3%)
$46.23 M(-16.9%)
Dec 2019
$55.61 M
$12.89 M(-14.2%)
$55.61 M(+8.8%)
Sep 2019
-
$15.03 M(+2.0%)
$51.10 M(+7.4%)
DateAnnualQuarterlyTTM
Jun 2019
-
$14.73 M(+13.7%)
$47.56 M(+8.9%)
Mar 2019
-
$12.96 M(+54.6%)
$43.66 M(+20.8%)
Dec 2018
$36.15 M(+630.9%)
$8.38 M(-27.1%)
$36.15 M(+10.1%)
Sep 2018
-
$11.50 M(+6.1%)
$32.83 M(+41.7%)
Jun 2018
-
$10.83 M(+99.0%)
$23.17 M(+96.7%)
Mar 2018
-
$5.44 M(+7.7%)
$11.78 M(+138.2%)
Dec 2017
$4.95 M(+422.3%)
$5.06 M(+174.7%)
$4.95 M(-738.2%)
Sep 2017
-
$1.84 M(-428.7%)
-$775.00 K(-76.6%)
Jun 2017
-
-$560.00 K(-59.8%)
-$3.32 M(+17.7%)
Mar 2017
-
-$1.39 M(+109.6%)
-$2.82 M(-397.6%)
Dec 2016
$947.00 K(-84.0%)
-$664.00 K(-5.1%)
$947.00 K(-76.1%)
Sep 2016
-
-$700.00 K(+1029.0%)
$3.96 M(-46.0%)
Jun 2016
-
-$62.00 K(-102.6%)
$7.32 M(+84.1%)
Mar 2016
-
$2.37 M(+1.2%)
$3.98 M(-33.0%)
Dec 2015
$5.93 M(+57.7%)
$2.35 M(-12.0%)
$5.93 M(+43.3%)
Sep 2015
-
$2.66 M(-178.2%)
$4.14 M(+109.3%)
Jun 2015
-
-$3.41 M(-178.7%)
$1.98 M(-63.3%)
Mar 2015
-
$4.33 M(+682.6%)
$5.38 M(+409.8%)
Dec 2014
$3.76 M(-937.4%)
$553.00 K(+9.9%)
$1.06 M(+109.9%)
Sep 2014
-
$503.00 K
$503.00 K
Dec 2013
-$449.00 K(-113.1%)
-
-
Dec 2012
$3.43 M
-
-

FAQ

  • What is Penumbra annual EBITDA?
  • What is the all time high annual EBITDA for Penumbra?
  • What is Penumbra annual EBITDA year-on-year change?
  • What is Penumbra quarterly EBITDA?
  • What is the all time high quarterly EBITDA for Penumbra?
  • What is Penumbra quarterly EBITDA year-on-year change?
  • What is Penumbra TTM EBITDA?
  • What is the all time high TTM EBITDA for Penumbra?
  • What is Penumbra TTM EBITDA year-on-year change?

What is Penumbra annual EBITDA?

The current annual EBITDA of PEN is $45.99 M

What is the all time high annual EBITDA for Penumbra?

Penumbra all-time high annual EBITDA is $108.65 M

What is Penumbra annual EBITDA year-on-year change?

Over the past year, PEN annual EBITDA has changed by -$62.66 M (-57.67%)

What is Penumbra quarterly EBITDA?

The current quarterly EBITDA of PEN is $49.06 M

What is the all time high quarterly EBITDA for Penumbra?

Penumbra all-time high quarterly EBITDA is $49.06 M

What is Penumbra quarterly EBITDA year-on-year change?

Over the past year, PEN quarterly EBITDA has changed by $0.00 (0.00%)

What is Penumbra TTM EBITDA?

The current TTM EBITDA of PEN is $43.06 M

What is the all time high TTM EBITDA for Penumbra?

Penumbra all-time high TTM EBITDA is $112.62 M

What is Penumbra TTM EBITDA year-on-year change?

Over the past year, PEN TTM EBITDA has changed by $0.00 (0.00%)